nodes	percent_of_prediction	percent_of_DWPC	metapath
Ketamine—GRIN2A—melanoma	0.667	0.869	CbGaD
Ketamine—ABCB1—melanoma	0.101	0.131	CbGaD
Ketamine—CYP3A4—Temozolomide—melanoma	0.0166	0.376	CbGbCtD
Ketamine—ABCB1—Dactinomycin—melanoma	0.0101	0.229	CbGbCtD
Ketamine—CYP3A4—Vemurafenib—melanoma	0.0091	0.206	CbGbCtD
Ketamine—ABCB1—Docetaxel—melanoma	0.00521	0.118	CbGbCtD
Ketamine—CYP3A4—Docetaxel—melanoma	0.00312	0.0707	CbGbCtD
Ketamine—Cystitis noninfective—Bleomycin—melanoma	0.000145	0.0456	CcSEcCtD
Ketamine—Cystitis—Bleomycin—melanoma	0.000143	0.0451	CcSEcCtD
Ketamine—Bladder pain—Bleomycin—melanoma	0.000134	0.0422	CcSEcCtD
Ketamine—Erythema—Vemurafenib—melanoma	0.000107	0.0337	CcSEcCtD
Ketamine—Diplopia—Carmustine—melanoma	9.41e-05	0.0296	CcSEcCtD
Ketamine—Diplopia—Temozolomide—melanoma	9.1e-05	0.0286	CcSEcCtD
Ketamine—Anaphylactic shock—Vemurafenib—melanoma	8.75e-05	0.0275	CcSEcCtD
Ketamine—Hypotension—Vemurafenib—melanoma	8.18e-05	0.0257	CcSEcCtD
Ketamine—Decreased appetite—Vemurafenib—melanoma	7.61e-05	0.0239	CcSEcCtD
Ketamine—Erythema—Bleomycin—melanoma	6.5e-05	0.0204	CcSEcCtD
Ketamine—Erythema—Dactinomycin—melanoma	6.06e-05	0.0191	CcSEcCtD
Ketamine—Arrhythmia—Carmustine—melanoma	5.82e-05	0.0183	CcSEcCtD
Ketamine—Erythema—Carmustine—melanoma	5.67e-05	0.0178	CcSEcCtD
Ketamine—Vomiting—Vemurafenib—melanoma	5.56e-05	0.0175	CcSEcCtD
Ketamine—Rash—Vemurafenib—melanoma	5.52e-05	0.0173	CcSEcCtD
Ketamine—Dermatitis—Vemurafenib—melanoma	5.51e-05	0.0173	CcSEcCtD
Ketamine—Erythema—Temozolomide—melanoma	5.48e-05	0.0172	CcSEcCtD
Ketamine—Vision blurred—Carmustine—melanoma	5.34e-05	0.0168	CcSEcCtD
Ketamine—Anaphylactic shock—Bleomycin—melanoma	5.3e-05	0.0167	CcSEcCtD
Ketamine—Nausea—Vemurafenib—melanoma	5.2e-05	0.0163	CcSEcCtD
Ketamine—Vision blurred—Temozolomide—melanoma	5.16e-05	0.0162	CcSEcCtD
Ketamine—Anorexia—Bleomycin—melanoma	5.05e-05	0.0159	CcSEcCtD
Ketamine—Hypotension—Bleomycin—melanoma	4.95e-05	0.0156	CcSEcCtD
Ketamine—Convulsion—Carmustine—melanoma	4.91e-05	0.0154	CcSEcCtD
Ketamine—Convulsion—Temozolomide—melanoma	4.75e-05	0.0149	CcSEcCtD
Ketamine—Anorexia—Dactinomycin—melanoma	4.71e-05	0.0148	CcSEcCtD
Ketamine—Decreased appetite—Bleomycin—melanoma	4.61e-05	0.0145	CcSEcCtD
Ketamine—Pain—Bleomycin—melanoma	4.53e-05	0.0143	CcSEcCtD
Ketamine—Anaphylactic shock—Temozolomide—melanoma	4.47e-05	0.0141	CcSEcCtD
Ketamine—Anorexia—Carmustine—melanoma	4.41e-05	0.0139	CcSEcCtD
Ketamine—Hypotension—Carmustine—melanoma	4.32e-05	0.0136	CcSEcCtD
Ketamine—Decreased appetite—Dactinomycin—melanoma	4.3e-05	0.0135	CcSEcCtD
Ketamine—Anorexia—Temozolomide—melanoma	4.26e-05	0.0134	CcSEcCtD
Ketamine—Pain—Dactinomycin—melanoma	4.23e-05	0.0133	CcSEcCtD
Ketamine—Decreased appetite—Carmustine—melanoma	4.02e-05	0.0126	CcSEcCtD
Ketamine—Pain—Carmustine—melanoma	3.96e-05	0.0124	CcSEcCtD
Ketamine—Decreased appetite—Temozolomide—melanoma	3.89e-05	0.0122	CcSEcCtD
Ketamine—Pain—Temozolomide—melanoma	3.82e-05	0.012	CcSEcCtD
Ketamine—Arrhythmia—Docetaxel—melanoma	3.74e-05	0.0118	CcSEcCtD
Ketamine—Erythema—Docetaxel—melanoma	3.64e-05	0.0115	CcSEcCtD
Ketamine—Vomiting—Bleomycin—melanoma	3.37e-05	0.0106	CcSEcCtD
Ketamine—Rash—Bleomycin—melanoma	3.34e-05	0.0105	CcSEcCtD
Ketamine—Dermatitis—Bleomycin—melanoma	3.34e-05	0.0105	CcSEcCtD
Ketamine—Convulsion—Docetaxel—melanoma	3.16e-05	0.00993	CcSEcCtD
Ketamine—Nausea—Bleomycin—melanoma	3.15e-05	0.0099	CcSEcCtD
Ketamine—Vomiting—Dactinomycin—melanoma	3.14e-05	0.00989	CcSEcCtD
Ketamine—Rash—Dactinomycin—melanoma	3.12e-05	0.0098	CcSEcCtD
Ketamine—Anaphylactic shock—Docetaxel—melanoma	2.97e-05	0.00935	CcSEcCtD
Ketamine—Vomiting—Carmustine—melanoma	2.94e-05	0.00925	CcSEcCtD
Ketamine—Nausea—Dactinomycin—melanoma	2.94e-05	0.00924	CcSEcCtD
Ketamine—Shock—Docetaxel—melanoma	2.93e-05	0.0092	CcSEcCtD
Ketamine—Rash—Carmustine—melanoma	2.92e-05	0.00917	CcSEcCtD
Ketamine—Dermatitis—Carmustine—melanoma	2.91e-05	0.00917	CcSEcCtD
Ketamine—Vomiting—Temozolomide—melanoma	2.84e-05	0.00894	CcSEcCtD
Ketamine—Anorexia—Docetaxel—melanoma	2.83e-05	0.00891	CcSEcCtD
Ketamine—Rash—Temozolomide—melanoma	2.82e-05	0.00887	CcSEcCtD
Ketamine—Dermatitis—Temozolomide—melanoma	2.82e-05	0.00886	CcSEcCtD
Ketamine—Hypotension—Docetaxel—melanoma	2.78e-05	0.00874	CcSEcCtD
Ketamine—Nausea—Carmustine—melanoma	2.75e-05	0.00864	CcSEcCtD
Ketamine—Nausea—Temozolomide—melanoma	2.66e-05	0.00835	CcSEcCtD
Ketamine—Decreased appetite—Docetaxel—melanoma	2.58e-05	0.00813	CcSEcCtD
Ketamine—Pain—Docetaxel—melanoma	2.54e-05	0.008	CcSEcCtD
Ketamine—Vomiting—Docetaxel—melanoma	1.89e-05	0.00595	CcSEcCtD
Ketamine—Rash—Docetaxel—melanoma	1.87e-05	0.0059	CcSEcCtD
Ketamine—Dermatitis—Docetaxel—melanoma	1.87e-05	0.00589	CcSEcCtD
Ketamine—Nausea—Docetaxel—melanoma	1.77e-05	0.00555	CcSEcCtD
Ketamine—DRD2—Signaling Pathways—E2F1—melanoma	5.82e-06	3.15e-05	CbGpPWpGaD
Ketamine—OPRD1—Signaling by GPCR—HRAS—melanoma	5.82e-06	3.14e-05	CbGpPWpGaD
Ketamine—ABCB1—Metabolism—GNAQ—melanoma	5.81e-06	3.14e-05	CbGpPWpGaD
Ketamine—ABCB1—Metabolism—CD44—melanoma	5.81e-06	3.14e-05	CbGpPWpGaD
Ketamine—DRD2—Signaling by GPCR—PIK3CB—melanoma	5.8e-06	3.13e-05	CbGpPWpGaD
Ketamine—DRD2—Signaling Pathways—PDGFRA—melanoma	5.76e-06	3.11e-05	CbGpPWpGaD
Ketamine—CYP2B6—Metabolism—PRKCA—melanoma	5.73e-06	3.09e-05	CbGpPWpGaD
Ketamine—OPRD1—Signaling Pathways—CDKN1B—melanoma	5.72e-06	3.09e-05	CbGpPWpGaD
Ketamine—CYP2C9—Metabolism—FASN—melanoma	5.72e-06	3.09e-05	CbGpPWpGaD
Ketamine—DRD2—Signaling Pathways—PRKCA—melanoma	5.71e-06	3.08e-05	CbGpPWpGaD
Ketamine—DRD2—Signaling Pathways—ITGB3—melanoma	5.71e-06	3.08e-05	CbGpPWpGaD
Ketamine—CYP2B6—Metabolism—ERCC2—melanoma	5.68e-06	3.07e-05	CbGpPWpGaD
Ketamine—PTGS1—Metabolism—PPARG—melanoma	5.67e-06	3.07e-05	CbGpPWpGaD
Ketamine—OPRD1—GPCR downstream signaling—AKT1—melanoma	5.66e-06	3.06e-05	CbGpPWpGaD
Ketamine—OPRM1—Signaling by GPCR—MAPK3—melanoma	5.65e-06	3.05e-05	CbGpPWpGaD
Ketamine—CYP2C8—Metabolism of lipids and lipoproteins—PTEN—melanoma	5.65e-06	3.05e-05	CbGpPWpGaD
Ketamine—CYP2C9—Metabolism—SLC5A5—melanoma	5.62e-06	3.04e-05	CbGpPWpGaD
Ketamine—OPRD1—Signaling Pathways—CASP3—melanoma	5.61e-06	3.03e-05	CbGpPWpGaD
Ketamine—OPRD1—Signaling Pathways—IL2—melanoma	5.6e-06	3.02e-05	CbGpPWpGaD
Ketamine—DRD2—Signaling Pathways—SPP1—melanoma	5.6e-06	3.02e-05	CbGpPWpGaD
Ketamine—DRD2—Signaling Pathways—MAP2K2—melanoma	5.58e-06	3.01e-05	CbGpPWpGaD
Ketamine—ABCB1—Metabolism—CYP1B1—melanoma	5.57e-06	3.01e-05	CbGpPWpGaD
Ketamine—OPRD1—Signaling by GPCR—IL6—melanoma	5.57e-06	3.01e-05	CbGpPWpGaD
Ketamine—DRD2—Signaling by GPCR—CXCL8—melanoma	5.57e-06	3.01e-05	CbGpPWpGaD
Ketamine—OPRM1—Signaling Pathways—BRAF—melanoma	5.54e-06	2.99e-05	CbGpPWpGaD
Ketamine—OPRK1—Signaling by GPCR—PIK3CA—melanoma	5.52e-06	2.98e-05	CbGpPWpGaD
Ketamine—OPRK1—Signaling Pathways—MDM2—melanoma	5.5e-06	2.97e-05	CbGpPWpGaD
Ketamine—OPRD1—Signaling Pathways—CCND1—melanoma	5.46e-06	2.95e-05	CbGpPWpGaD
Ketamine—CYP2C9—Metabolism—GNAQ—melanoma	5.43e-06	2.93e-05	CbGpPWpGaD
Ketamine—CYP2C9—Metabolism—CD44—melanoma	5.43e-06	2.93e-05	CbGpPWpGaD
Ketamine—OPRK1—Signaling Pathways—ERBB2—melanoma	5.42e-06	2.93e-05	CbGpPWpGaD
Ketamine—OPRD1—Signaling Pathways—CTNNB1—melanoma	5.41e-06	2.92e-05	CbGpPWpGaD
Ketamine—OPRM1—Signaling Pathways—IGF1—melanoma	5.4e-06	2.92e-05	CbGpPWpGaD
Ketamine—TACR1—Signaling Pathways—AKT1—melanoma	5.39e-06	2.91e-05	CbGpPWpGaD
Ketamine—CYP3A4—Metabolism—PLA2G6—melanoma	5.38e-06	2.91e-05	CbGpPWpGaD
Ketamine—OPRM1—Signaling by GPCR—MAPK1—melanoma	5.37e-06	2.9e-05	CbGpPWpGaD
Ketamine—OPRM1—Signaling by GPCR—EGFR—melanoma	5.37e-06	2.9e-05	CbGpPWpGaD
Ketamine—OPRK1—Signaling Pathways—PIK3CB—melanoma	5.35e-06	2.89e-05	CbGpPWpGaD
Ketamine—DRD2—Signaling by GPCR—IL2—melanoma	5.32e-06	2.88e-05	CbGpPWpGaD
Ketamine—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CB—melanoma	5.32e-06	2.87e-05	CbGpPWpGaD
Ketamine—DRD2—Signaling Pathways—TERT—melanoma	5.3e-06	2.87e-05	CbGpPWpGaD
Ketamine—OPRD1—Signaling Pathways—MMP9—melanoma	5.3e-06	2.86e-05	CbGpPWpGaD
Ketamine—DRD2—Signaling Pathways—RAC1—melanoma	5.29e-06	2.86e-05	CbGpPWpGaD
Ketamine—OPRD1—Signaling Pathways—CDKN1A—melanoma	5.28e-06	2.85e-05	CbGpPWpGaD
Ketamine—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—melanoma	5.27e-06	2.85e-05	CbGpPWpGaD
Ketamine—OPRD1—Signaling Pathways—PTEN—melanoma	5.27e-06	2.85e-05	CbGpPWpGaD
Ketamine—CYP2C8—Metabolism—ABCB1—melanoma	5.27e-06	2.85e-05	CbGpPWpGaD
Ketamine—OPRD1—Signaling Pathways—NFKB1—melanoma	5.24e-06	2.83e-05	CbGpPWpGaD
Ketamine—OPRM1—Signaling Pathways—MAP2K1—melanoma	5.22e-06	2.82e-05	CbGpPWpGaD
Ketamine—CYP2C9—Metabolism—CYP1B1—melanoma	5.21e-06	2.81e-05	CbGpPWpGaD
Ketamine—OPRM1—Signaling Pathways—PIK3CD—melanoma	5.18e-06	2.8e-05	CbGpPWpGaD
Ketamine—PTGS1—Metabolism—PIK3CD—melanoma	5.17e-06	2.79e-05	CbGpPWpGaD
Ketamine—OPRD1—Signaling by GPCR—AKT1—melanoma	5.14e-06	2.78e-05	CbGpPWpGaD
Ketamine—OPRK1—Signaling Pathways—CXCL8—melanoma	5.14e-06	2.78e-05	CbGpPWpGaD
Ketamine—OPRM1—GPCR downstream signaling—PIK3CA—melanoma	5.13e-06	2.77e-05	CbGpPWpGaD
Ketamine—OPRK1—Signaling by GPCR—HRAS—melanoma	5.1e-06	2.76e-05	CbGpPWpGaD
Ketamine—PTGS1—Metabolism—ALB—melanoma	5.1e-06	2.76e-05	CbGpPWpGaD
Ketamine—OPRM1—Signaling by GPCR—KRAS—melanoma	5.08e-06	2.74e-05	CbGpPWpGaD
Ketamine—DRD2—Signaling Pathways—HIF1A—melanoma	5.07e-06	2.74e-05	CbGpPWpGaD
Ketamine—OPRK1—Signaling Pathways—CDKN1B—melanoma	5.02e-06	2.71e-05	CbGpPWpGaD
Ketamine—OPRM1—Signaling Pathways—FGF2—melanoma	4.96e-06	2.68e-05	CbGpPWpGaD
Ketamine—OPRK1—GPCR downstream signaling—AKT1—melanoma	4.96e-06	2.68e-05	CbGpPWpGaD
Ketamine—OPRK1—Signaling Pathways—CASP3—melanoma	4.92e-06	2.66e-05	CbGpPWpGaD
Ketamine—OPRK1—Signaling Pathways—IL2—melanoma	4.91e-06	2.65e-05	CbGpPWpGaD
Ketamine—OPRK1—Signaling by GPCR—IL6—melanoma	4.89e-06	2.64e-05	CbGpPWpGaD
Ketamine—DRD2—Signaling Pathways—KDR—melanoma	4.85e-06	2.62e-05	CbGpPWpGaD
Ketamine—CYP2C8—Metabolism—PRKCA—melanoma	4.85e-06	2.62e-05	CbGpPWpGaD
Ketamine—CYP3A4—Metabolism—VCAN—melanoma	4.84e-06	2.61e-05	CbGpPWpGaD
Ketamine—CYP2C8—Metabolism—ERCC2—melanoma	4.81e-06	2.6e-05	CbGpPWpGaD
Ketamine—OPRK1—Signaling Pathways—CCND1—melanoma	4.79e-06	2.59e-05	CbGpPWpGaD
Ketamine—OPRD1—Signaling Pathways—VEGFA—melanoma	4.76e-06	2.57e-05	CbGpPWpGaD
Ketamine—OPRK1—Signaling Pathways—CTNNB1—melanoma	4.74e-06	2.56e-05	CbGpPWpGaD
Ketamine—OPRD1—Signaling Pathways—STAT3—melanoma	4.71e-06	2.55e-05	CbGpPWpGaD
Ketamine—OPRD1—Signaling Pathways—NRAS—melanoma	4.7e-06	2.54e-05	CbGpPWpGaD
Ketamine—DRD2—Signaling Pathways—FN1—melanoma	4.67e-06	2.52e-05	CbGpPWpGaD
Ketamine—OPRM1—Signaling by GPCR—PIK3CA—melanoma	4.66e-06	2.52e-05	CbGpPWpGaD
Ketamine—OPRK1—Signaling Pathways—MMP9—melanoma	4.65e-06	2.51e-05	CbGpPWpGaD
Ketamine—OPRM1—Signaling Pathways—MDM2—melanoma	4.64e-06	2.51e-05	CbGpPWpGaD
Ketamine—OPRK1—Signaling Pathways—CDKN1A—melanoma	4.63e-06	2.5e-05	CbGpPWpGaD
Ketamine—OPRK1—Signaling Pathways—PTEN—melanoma	4.62e-06	2.5e-05	CbGpPWpGaD
Ketamine—OPRK1—Signaling Pathways—NFKB1—melanoma	4.6e-06	2.48e-05	CbGpPWpGaD
Ketamine—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—melanoma	4.6e-06	2.48e-05	CbGpPWpGaD
Ketamine—OPRM1—Signaling Pathways—ERBB2—melanoma	4.58e-06	2.47e-05	CbGpPWpGaD
Ketamine—DRD2—Signaling Pathways—NOTCH1—melanoma	4.57e-06	2.47e-05	CbGpPWpGaD
Ketamine—OPRM1—Signaling Pathways—PIK3CB—melanoma	4.52e-06	2.44e-05	CbGpPWpGaD
Ketamine—OPRK1—Signaling by GPCR—AKT1—melanoma	4.51e-06	2.43e-05	CbGpPWpGaD
Ketamine—PTGS1—Metabolism—PIK3CB—melanoma	4.5e-06	2.43e-05	CbGpPWpGaD
Ketamine—OPRD1—Signaling Pathways—MAPK3—melanoma	4.5e-06	2.43e-05	CbGpPWpGaD
Ketamine—CYP2B6—Metabolism—PIK3CG—melanoma	4.49e-06	2.42e-05	CbGpPWpGaD
Ketamine—DRD2—Signaling Pathways—CD80—melanoma	4.48e-06	2.42e-05	CbGpPWpGaD
Ketamine—DRD2—Signaling Pathways—APC—melanoma	4.47e-06	2.41e-05	CbGpPWpGaD
Ketamine—DRD2—Signaling Pathways—PIK3CG—melanoma	4.47e-06	2.41e-05	CbGpPWpGaD
Ketamine—DRD2—Signaling Pathways—KIT—melanoma	4.47e-06	2.41e-05	CbGpPWpGaD
Ketamine—DRD2—Signaling by GPCR—NRAS—melanoma	4.47e-06	2.41e-05	CbGpPWpGaD
Ketamine—PTGS1—Metabolism—PTGS2—melanoma	4.46e-06	2.41e-05	CbGpPWpGaD
Ketamine—DRD2—Signaling Pathways—EGF—melanoma	4.42e-06	2.39e-05	CbGpPWpGaD
Ketamine—OPRD1—Signaling Pathways—MYC—melanoma	4.38e-06	2.37e-05	CbGpPWpGaD
Ketamine—OPRM1—Signaling Pathways—CXCL8—melanoma	4.34e-06	2.35e-05	CbGpPWpGaD
Ketamine—CYP2B6—Metabolism—PPARG—melanoma	4.33e-06	2.34e-05	CbGpPWpGaD
Ketamine—OPRM1—Signaling by GPCR—HRAS—melanoma	4.31e-06	2.33e-05	CbGpPWpGaD
Ketamine—CYP2C9—Metabolism—ABCB1—melanoma	4.29e-06	2.32e-05	CbGpPWpGaD
Ketamine—OPRD1—Signaling Pathways—MAPK1—melanoma	4.28e-06	2.31e-05	CbGpPWpGaD
Ketamine—OPRD1—Signaling Pathways—EGFR—melanoma	4.28e-06	2.31e-05	CbGpPWpGaD
Ketamine—DRD2—Signaling by GPCR—MAPK3—melanoma	4.28e-06	2.31e-05	CbGpPWpGaD
Ketamine—OPRM1—Signaling Pathways—CDKN1B—melanoma	4.24e-06	2.29e-05	CbGpPWpGaD
Ketamine—ABCB1—Metabolism—PRKCA—melanoma	4.22e-06	2.28e-05	CbGpPWpGaD
Ketamine—DRD2—Signaling Pathways—BRAF—melanoma	4.2e-06	2.27e-05	CbGpPWpGaD
Ketamine—OPRM1—GPCR downstream signaling—AKT1—melanoma	4.19e-06	2.27e-05	CbGpPWpGaD
Ketamine—ABCB1—Metabolism—ERCC2—melanoma	4.19e-06	2.26e-05	CbGpPWpGaD
Ketamine—OPRK1—Signaling Pathways—VEGFA—melanoma	4.17e-06	2.25e-05	CbGpPWpGaD
Ketamine—OPRM1—Signaling Pathways—CASP3—melanoma	4.16e-06	2.24e-05	CbGpPWpGaD
Ketamine—OPRM1—Signaling Pathways—IL2—melanoma	4.15e-06	2.24e-05	CbGpPWpGaD
Ketamine—OPRK1—Signaling Pathways—STAT3—melanoma	4.13e-06	2.23e-05	CbGpPWpGaD
Ketamine—OPRM1—Signaling by GPCR—IL6—melanoma	4.13e-06	2.23e-05	CbGpPWpGaD
Ketamine—OPRK1—Signaling Pathways—NRAS—melanoma	4.12e-06	2.23e-05	CbGpPWpGaD
Ketamine—DRD2—Signaling Pathways—IGF1—melanoma	4.09e-06	2.21e-05	CbGpPWpGaD
Ketamine—CYP3A4—Metabolism—CYP17A1—melanoma	4.08e-06	2.2e-05	CbGpPWpGaD
Ketamine—DRD2—Signaling by GPCR—MAPK1—melanoma	4.07e-06	2.2e-05	CbGpPWpGaD
Ketamine—DRD2—Signaling by GPCR—EGFR—melanoma	4.07e-06	2.2e-05	CbGpPWpGaD
Ketamine—OPRD1—Signaling Pathways—KRAS—melanoma	4.05e-06	2.19e-05	CbGpPWpGaD
Ketamine—OPRM1—Signaling Pathways—CCND1—melanoma	4.05e-06	2.19e-05	CbGpPWpGaD
Ketamine—OPRM1—Signaling Pathways—CTNNB1—melanoma	4.01e-06	2.16e-05	CbGpPWpGaD
Ketamine—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CA—melanoma	3.98e-06	2.15e-05	CbGpPWpGaD
Ketamine—DRD2—Signaling Pathways—MAP2K1—melanoma	3.95e-06	2.14e-05	CbGpPWpGaD
Ketamine—OPRK1—Signaling Pathways—MAPK3—melanoma	3.95e-06	2.13e-05	CbGpPWpGaD
Ketamine—CYP2C9—Metabolism—PRKCA—melanoma	3.95e-06	2.13e-05	CbGpPWpGaD
Ketamine—CYP2B6—Metabolism—PIK3CD—melanoma	3.94e-06	2.13e-05	CbGpPWpGaD
Ketamine—DRD2—Signaling Pathways—PIK3CD—melanoma	3.93e-06	2.12e-05	CbGpPWpGaD
Ketamine—OPRM1—Signaling Pathways—MMP9—melanoma	3.93e-06	2.12e-05	CbGpPWpGaD
Ketamine—CYP2C9—Metabolism—ERCC2—melanoma	3.91e-06	2.11e-05	CbGpPWpGaD
Ketamine—OPRM1—Signaling Pathways—CDKN1A—melanoma	3.91e-06	2.11e-05	CbGpPWpGaD
Ketamine—OPRM1—Signaling Pathways—PTEN—melanoma	3.9e-06	2.11e-05	CbGpPWpGaD
Ketamine—PTGS1—Metabolism—PTEN—melanoma	3.89e-06	2.1e-05	CbGpPWpGaD
Ketamine—CYP2B6—Metabolism—ALB—melanoma	3.89e-06	2.1e-05	CbGpPWpGaD
Ketamine—DRD2—GPCR downstream signaling—PIK3CA—melanoma	3.89e-06	2.1e-05	CbGpPWpGaD
Ketamine—OPRM1—Signaling Pathways—NFKB1—melanoma	3.89e-06	2.1e-05	CbGpPWpGaD
Ketamine—CYP3A4—Metabolism—GNA11—melanoma	3.85e-06	2.08e-05	CbGpPWpGaD
Ketamine—DRD2—Signaling by GPCR—KRAS—melanoma	3.85e-06	2.08e-05	CbGpPWpGaD
Ketamine—OPRK1—Signaling Pathways—MYC—melanoma	3.84e-06	2.07e-05	CbGpPWpGaD
Ketamine—OPRM1—Signaling by GPCR—AKT1—melanoma	3.81e-06	2.06e-05	CbGpPWpGaD
Ketamine—CYP2C8—Metabolism—PIK3CG—melanoma	3.8e-06	2.05e-05	CbGpPWpGaD
Ketamine—CYP3A4—Metabolism—FASN—melanoma	3.77e-06	2.04e-05	CbGpPWpGaD
Ketamine—DRD2—Signaling Pathways—FGF2—melanoma	3.76e-06	2.03e-05	CbGpPWpGaD
Ketamine—OPRK1—Signaling Pathways—MAPK1—melanoma	3.76e-06	2.03e-05	CbGpPWpGaD
Ketamine—OPRK1—Signaling Pathways—EGFR—melanoma	3.76e-06	2.03e-05	CbGpPWpGaD
Ketamine—OPRD1—Signaling Pathways—PIK3CA—melanoma	3.72e-06	2.01e-05	CbGpPWpGaD
Ketamine—CYP3A4—Metabolism—SLC5A5—melanoma	3.71e-06	2e-05	CbGpPWpGaD
Ketamine—CYP2C8—Metabolism—PPARG—melanoma	3.67e-06	1.98e-05	CbGpPWpGaD
Ketamine—OPRD1—Signaling Pathways—TP53—melanoma	3.6e-06	1.94e-05	CbGpPWpGaD
Ketamine—CYP3A4—Metabolism—GNAQ—melanoma	3.58e-06	1.93e-05	CbGpPWpGaD
Ketamine—CYP3A4—Metabolism—CD44—melanoma	3.58e-06	1.93e-05	CbGpPWpGaD
Ketamine—OPRK1—Signaling Pathways—KRAS—melanoma	3.55e-06	1.92e-05	CbGpPWpGaD
Ketamine—DRD2—Signaling by GPCR—PIK3CA—melanoma	3.53e-06	1.91e-05	CbGpPWpGaD
Ketamine—OPRM1—Signaling Pathways—VEGFA—melanoma	3.53e-06	1.91e-05	CbGpPWpGaD
Ketamine—DRD2—Signaling Pathways—MDM2—melanoma	3.52e-06	1.9e-05	CbGpPWpGaD
Ketamine—OPRM1—Signaling Pathways—STAT3—melanoma	3.49e-06	1.89e-05	CbGpPWpGaD
Ketamine—OPRM1—Signaling Pathways—NRAS—melanoma	3.48e-06	1.88e-05	CbGpPWpGaD
Ketamine—DRD2—Signaling Pathways—ERBB2—melanoma	3.47e-06	1.87e-05	CbGpPWpGaD
Ketamine—OPRD1—Signaling Pathways—HRAS—melanoma	3.44e-06	1.86e-05	CbGpPWpGaD
Ketamine—CYP2B6—Metabolism—PIK3CB—melanoma	3.44e-06	1.86e-05	CbGpPWpGaD
Ketamine—CYP3A4—Metabolism—CYP1B1—melanoma	3.43e-06	1.85e-05	CbGpPWpGaD
Ketamine—DRD2—Signaling Pathways—PIK3CB—melanoma	3.42e-06	1.85e-05	CbGpPWpGaD
Ketamine—CYP2B6—Metabolism—PTGS2—melanoma	3.41e-06	1.84e-05	CbGpPWpGaD
Ketamine—CYP2C8—Metabolism—PIK3CD—melanoma	3.34e-06	1.8e-05	CbGpPWpGaD
Ketamine—OPRM1—Signaling Pathways—MAPK3—melanoma	3.34e-06	1.8e-05	CbGpPWpGaD
Ketamine—ABCB1—Metabolism—PIK3CG—melanoma	3.31e-06	1.79e-05	CbGpPWpGaD
Ketamine—CYP2C8—Metabolism—ALB—melanoma	3.3e-06	1.78e-05	CbGpPWpGaD
Ketamine—OPRD1—Signaling Pathways—IL6—melanoma	3.29e-06	1.78e-05	CbGpPWpGaD
Ketamine—DRD2—Signaling Pathways—CXCL8—melanoma	3.29e-06	1.78e-05	CbGpPWpGaD
Ketamine—DRD2—Signaling by GPCR—HRAS—melanoma	3.27e-06	1.77e-05	CbGpPWpGaD
Ketamine—OPRK1—Signaling Pathways—PIK3CA—melanoma	3.26e-06	1.76e-05	CbGpPWpGaD
Ketamine—OPRM1—Signaling Pathways—MYC—melanoma	3.24e-06	1.75e-05	CbGpPWpGaD
Ketamine—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—melanoma	3.24e-06	1.75e-05	CbGpPWpGaD
Ketamine—DRD2—Signaling Pathways—CDKN1B—melanoma	3.21e-06	1.74e-05	CbGpPWpGaD
Ketamine—ABCB1—Metabolism—PPARG—melanoma	3.19e-06	1.72e-05	CbGpPWpGaD
Ketamine—DRD2—GPCR downstream signaling—AKT1—melanoma	3.18e-06	1.72e-05	CbGpPWpGaD
Ketamine—OPRM1—Signaling Pathways—MAPK1—melanoma	3.17e-06	1.71e-05	CbGpPWpGaD
Ketamine—OPRM1—Signaling Pathways—EGFR—melanoma	3.17e-06	1.71e-05	CbGpPWpGaD
Ketamine—OPRK1—Signaling Pathways—TP53—melanoma	3.15e-06	1.7e-05	CbGpPWpGaD
Ketamine—DRD2—Signaling Pathways—CASP3—melanoma	3.15e-06	1.7e-05	CbGpPWpGaD
Ketamine—DRD2—Signaling Pathways—IL2—melanoma	3.14e-06	1.7e-05	CbGpPWpGaD
Ketamine—DRD2—Signaling by GPCR—IL6—melanoma	3.13e-06	1.69e-05	CbGpPWpGaD
Ketamine—CYP2C9—Metabolism—PIK3CG—melanoma	3.09e-06	1.67e-05	CbGpPWpGaD
Ketamine—DRD2—Signaling Pathways—CCND1—melanoma	3.07e-06	1.66e-05	CbGpPWpGaD
Ketamine—OPRD1—Signaling Pathways—AKT1—melanoma	3.04e-06	1.64e-05	CbGpPWpGaD
Ketamine—DRD2—Signaling Pathways—CTNNB1—melanoma	3.04e-06	1.64e-05	CbGpPWpGaD
Ketamine—OPRK1—Signaling Pathways—HRAS—melanoma	3.02e-06	1.63e-05	CbGpPWpGaD
Ketamine—OPRM1—Signaling Pathways—KRAS—melanoma	3e-06	1.62e-05	CbGpPWpGaD
Ketamine—CYP2C9—Metabolism—PPARG—melanoma	2.98e-06	1.61e-05	CbGpPWpGaD
Ketamine—DRD2—Signaling Pathways—MMP9—melanoma	2.98e-06	1.61e-05	CbGpPWpGaD
Ketamine—CYP2B6—Metabolism—PTEN—melanoma	2.97e-06	1.6e-05	CbGpPWpGaD
Ketamine—DRD2—Signaling Pathways—CDKN1A—melanoma	2.97e-06	1.6e-05	CbGpPWpGaD
Ketamine—DRD2—Signaling Pathways—PTEN—melanoma	2.96e-06	1.6e-05	CbGpPWpGaD
Ketamine—DRD2—Signaling Pathways—NFKB1—melanoma	2.94e-06	1.59e-05	CbGpPWpGaD
Ketamine—CYP2C8—Metabolism—PIK3CB—melanoma	2.91e-06	1.57e-05	CbGpPWpGaD
Ketamine—ABCB1—Metabolism—PIK3CD—melanoma	2.91e-06	1.57e-05	CbGpPWpGaD
Ketamine—DRD2—Signaling by GPCR—AKT1—melanoma	2.89e-06	1.56e-05	CbGpPWpGaD
Ketamine—OPRK1—Signaling Pathways—IL6—melanoma	2.89e-06	1.56e-05	CbGpPWpGaD
Ketamine—CYP2C8—Metabolism—PTGS2—melanoma	2.88e-06	1.56e-05	CbGpPWpGaD
Ketamine—ABCB1—Metabolism—ALB—melanoma	2.87e-06	1.55e-05	CbGpPWpGaD
Ketamine—CYP3A4—Metabolism—ABCB1—melanoma	2.83e-06	1.53e-05	CbGpPWpGaD
Ketamine—OPRM1—Signaling Pathways—PIK3CA—melanoma	2.75e-06	1.49e-05	CbGpPWpGaD
Ketamine—PTGS1—Metabolism—PIK3CA—melanoma	2.75e-06	1.48e-05	CbGpPWpGaD
Ketamine—CYP2C9—Metabolism—PIK3CD—melanoma	2.72e-06	1.47e-05	CbGpPWpGaD
Ketamine—CYP2C9—Metabolism—ALB—melanoma	2.68e-06	1.45e-05	CbGpPWpGaD
Ketamine—DRD2—Signaling Pathways—VEGFA—melanoma	2.67e-06	1.44e-05	CbGpPWpGaD
Ketamine—OPRM1—Signaling Pathways—TP53—melanoma	2.66e-06	1.44e-05	CbGpPWpGaD
Ketamine—OPRK1—Signaling Pathways—AKT1—melanoma	2.66e-06	1.44e-05	CbGpPWpGaD
Ketamine—DRD2—Signaling Pathways—STAT3—melanoma	2.65e-06	1.43e-05	CbGpPWpGaD
Ketamine—DRD2—Signaling Pathways—NRAS—melanoma	2.64e-06	1.43e-05	CbGpPWpGaD
Ketamine—CYP3A4—Metabolism—PRKCA—melanoma	2.6e-06	1.41e-05	CbGpPWpGaD
Ketamine—CYP3A4—Metabolism—ERCC2—melanoma	2.58e-06	1.39e-05	CbGpPWpGaD
Ketamine—OPRM1—Signaling Pathways—HRAS—melanoma	2.55e-06	1.38e-05	CbGpPWpGaD
Ketamine—ABCB1—Metabolism—PIK3CB—melanoma	2.54e-06	1.37e-05	CbGpPWpGaD
Ketamine—DRD2—Signaling Pathways—MAPK3—melanoma	2.53e-06	1.37e-05	CbGpPWpGaD
Ketamine—CYP2C8—Metabolism—PTEN—melanoma	2.51e-06	1.36e-05	CbGpPWpGaD
Ketamine—ABCB1—Metabolism—PTGS2—melanoma	2.51e-06	1.36e-05	CbGpPWpGaD
Ketamine—DRD2—Signaling Pathways—MYC—melanoma	2.46e-06	1.33e-05	CbGpPWpGaD
Ketamine—OPRM1—Signaling Pathways—IL6—melanoma	2.44e-06	1.32e-05	CbGpPWpGaD
Ketamine—DRD2—Signaling Pathways—MAPK1—melanoma	2.41e-06	1.3e-05	CbGpPWpGaD
Ketamine—DRD2—Signaling Pathways—EGFR—melanoma	2.41e-06	1.3e-05	CbGpPWpGaD
Ketamine—CYP2C9—Metabolism—PIK3CB—melanoma	2.37e-06	1.28e-05	CbGpPWpGaD
Ketamine—CYP2C9—Metabolism—PTGS2—melanoma	2.35e-06	1.27e-05	CbGpPWpGaD
Ketamine—DRD2—Signaling Pathways—KRAS—melanoma	2.27e-06	1.23e-05	CbGpPWpGaD
Ketamine—OPRM1—Signaling Pathways—AKT1—melanoma	2.25e-06	1.22e-05	CbGpPWpGaD
Ketamine—PTGS1—Metabolism—AKT1—melanoma	2.24e-06	1.21e-05	CbGpPWpGaD
Ketamine—ABCB1—Metabolism—PTEN—melanoma	2.19e-06	1.18e-05	CbGpPWpGaD
Ketamine—CYP2B6—Metabolism—PIK3CA—melanoma	2.1e-06	1.13e-05	CbGpPWpGaD
Ketamine—DRD2—Signaling Pathways—PIK3CA—melanoma	2.09e-06	1.13e-05	CbGpPWpGaD
Ketamine—CYP2C9—Metabolism—PTEN—melanoma	2.05e-06	1.11e-05	CbGpPWpGaD
Ketamine—CYP3A4—Metabolism—PIK3CG—melanoma	2.04e-06	1.1e-05	CbGpPWpGaD
Ketamine—DRD2—Signaling Pathways—TP53—melanoma	2.02e-06	1.09e-05	CbGpPWpGaD
Ketamine—CYP3A4—Metabolism—PPARG—melanoma	1.97e-06	1.06e-05	CbGpPWpGaD
Ketamine—DRD2—Signaling Pathways—HRAS—melanoma	1.93e-06	1.04e-05	CbGpPWpGaD
Ketamine—DRD2—Signaling Pathways—IL6—melanoma	1.85e-06	9.99e-06	CbGpPWpGaD
Ketamine—CYP3A4—Metabolism—PIK3CD—melanoma	1.79e-06	9.68e-06	CbGpPWpGaD
Ketamine—CYP2C8—Metabolism—PIK3CA—melanoma	1.77e-06	9.58e-06	CbGpPWpGaD
Ketamine—CYP3A4—Metabolism—ALB—melanoma	1.77e-06	9.56e-06	CbGpPWpGaD
Ketamine—CYP2B6—Metabolism—AKT1—melanoma	1.71e-06	9.25e-06	CbGpPWpGaD
Ketamine—DRD2—Signaling Pathways—AKT1—melanoma	1.71e-06	9.21e-06	CbGpPWpGaD
Ketamine—CYP3A4—Metabolism—PIK3CB—melanoma	1.56e-06	8.44e-06	CbGpPWpGaD
Ketamine—CYP3A4—Metabolism—PTGS2—melanoma	1.55e-06	8.36e-06	CbGpPWpGaD
Ketamine—ABCB1—Metabolism—PIK3CA—melanoma	1.55e-06	8.35e-06	CbGpPWpGaD
Ketamine—CYP2C8—Metabolism—AKT1—melanoma	1.45e-06	7.83e-06	CbGpPWpGaD
Ketamine—CYP2C9—Metabolism—PIK3CA—melanoma	1.44e-06	7.8e-06	CbGpPWpGaD
Ketamine—CYP3A4—Metabolism—PTEN—melanoma	1.35e-06	7.29e-06	CbGpPWpGaD
Ketamine—ABCB1—Metabolism—AKT1—melanoma	1.26e-06	6.82e-06	CbGpPWpGaD
Ketamine—CYP2C9—Metabolism—AKT1—melanoma	1.18e-06	6.37e-06	CbGpPWpGaD
Ketamine—CYP3A4—Metabolism—PIK3CA—melanoma	9.52e-07	5.14e-06	CbGpPWpGaD
Ketamine—CYP3A4—Metabolism—AKT1—melanoma	7.78e-07	4.2e-06	CbGpPWpGaD
